Atlas Trials

Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease

Clinical trial NCT00121602 · COMPLETED

Trial details

NCT number
NCT00121602
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
AnemiaKidney Disease
Start date
2005-03-01
Primary completion
2005-10-01
Enrollment
446

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.